Trials / Unknown
UnknownNCT01834508
3E Extension Study
A 3-year, Open-lable, Multi-center Extension Trial of Entecavir Plus Adefovir Combination Treatment for Patients Previously Treated in EXPLORE, EXCEL and EFFORT Ex Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the long-term efficacy and safety of entecavir 0.5 mg/d + adefovir 10 mg/d for treatment experienced chronic hepatitis B patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks |
Timeline
- Start date
- 2013-03-01
- Primary completion
- 2016-06-01
- Completion
- 2016-12-01
- First posted
- 2013-04-18
- Last updated
- 2014-06-19
Locations
28 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01834508. Inclusion in this directory is not an endorsement.